The effect of sublethal gamma radiation on inbred mice chronically infected with scrub typhus rickettsiae was examined. Inbred mice which were inoculated with the Gilliam or Karp strain of Rickettsia tsutsugamushi by the subcutaneous route harbored the infection for at least 1 year. Irradiation of these animals at 12 or 52 weeks postinoculation with normally sublethal levels induced a significantly higher percentage of rickettsemic mice (recrudescence) tha.n was seen in the unirradiated, similarly infected control animals. In addition, sublethal irradiation at 12 weeks induced a quantitative increase in total rickettsiae. Homologous antibody titers to the rickettsiae were examined for 5 weeks after irradiation to determine the role of the humoral response in radiation-induced recrudescence. Unirradiated, infected mice showed consistent titers of about 320 throughout the 5-week observation period, and the titer was not affected by exposure of up to 500 rads of gamma radiation. Drug dose-dependent radioprotection and modification of recrudescence was noted ip infected, irradiated mice treated with the antiradiation compound S-2-(3-aminopropylamino)ethyl phosphorothioic acid. The results of this investigation supported the conclusion that the recrudescence of a chronic rickettsial infection in the appropriate host after immunological impairment due to gamma radiation can result in an acute, possibly lethal rickettsemia.
The effect of sublethal gamma radiation on inbred mice chronically infected with scrub typhus rickettsiae was examined. Inbred mice which were inoculated with the Gilliam or Karp strain of Rickettsia tsutsugamushi by the subcutaneous route harbored the infection for at least 1 year. Irradiation of these animals at 12 or 52 weeks postinoculation with normally sublethal levels induced a significantly higher percentage of rickettsemic mice (recrudescence) tha.n was seen in the unirradiated, similarly infected control animals. In addition, sublethal irradiation at 12 weeks induced a quantitative increase in total rickettsiae. Homologous antibody titers to the rickettsiae were examined for 5 weeks after irradiation to determine the role of the humoral response in radiation-induced recrudescence. Unirradiated, infected mice showed consistent titers of about 320 throughout the 5-week observation period, and the titer was not affected by exposure of up to 500 rads of gamma radiation. Drug dose-dependent radioprotection and modification of recrudescence was noted ip infected, irradiated mice treated with the antiradiation compound S-2-(3-aminopropylamino)ethyl phosphorothioic acid. The results of this investigation supported the conclusion that the recrudescence of a chronic rickettsial infection in the appropriate host after immunological impairment due to gamma radiation can result in an acute, possibly lethal rickettsemia.
Recrudescence of rickettsial infection was first observed in epidemic typhus patients and occurred many years after their primary infection with Rickettsia prowazekii. This form of epidemic typhus occurs in the absence of a vector and is known as recrudescent typhus or Brill-Zinsser disease (4) . Alterations in the physiological or immunological status of the aging host may play a role in the recrudescence of disease, but a specific mechanism has not been described. This spontaneous recurrence of infection in humans has not been observed in other rickettsial diseases, but there are data to document that Rickettsia rickettsii (18) and R. tsutsugamushi (23) are harbored in the tissues of humans or laboratory rodents for over a year after primary infection.
Mice experimentally infected with scrub typhus have been induced to recrudesce up to 1 year after infection by impairing immune function with cyclophosphamide (21) . This evidence suggests that generalized immunological impairment, which might occur due to exposure to sublethal radiation, may induce recrudescence in chronically infected humans or those immunized with living agents.
It has long been recognized that variations in virulence can be related to the strain of R. tsutsugamushi (9) (10) (11) , the route of inoculation (10) , and the genetic susceptibility of the host (9, 16) . The mouse scrub typhus model used in this investigation allowed both a thorough examination of radiationinduced rickettsial recrudescence and an examination of the effect of various virulence determinants which bear upon that recrudescence.
The purpose of this study was to examine the effect of gamma radiation on the recrudescence of experimental scrub typhus in mice convalescing from infection with R. tsu-tsugamushi. The parameters selected to examine recrudescence were the temporal onset of rickettsemia, the quantification of circulating rickettsiae, the influence of the humoral response, and the sparing effect of radioprotective drugs.
MATERIALS AND METHODS
Animals. Female BALB/cDub and C3H/HeDub mice were obtained from Flow Laboratories Inc. (Dublin, Va.) and used at an age of 8 to 12 weeks.
Rickettsiae. The Karp (52nd egg passage), and Gilliam (164th egg passage) strains of R. tsutsugamushi were plaque purified (17) , propagated, stored, and quantified as previously reported (5) .
Animal infection. Mice were infected with either the Karp or Gilliam strain of R. tsutsugamushi by a single subcutaneous (s.c.) inoculation of 0.2 mnl of rickettsial suspension containing 1,000 intraperitoneal (i.p.) 50% mouse lethal doses (MLD50). Previous studies have demonstrated this route of inoculation to be immunizing and nonlethal in mice (22) .
Animal irradiation. Mice were exposed to various doses of radiation at 12 weeks or 52 weeks after rickettsial infection by using '37Cs radiation (Gammacell 40; Atomic Energy of Canada Ltd., Ottawa, Canada) at a rate of 123 rads per min. Normal and infected mice were observed for 30 days, and the radiation MLD50 was determined by the method of Spearman and Karber (7) .
Qualitative evaluation of rickettsemia. At various times after radiation, infected mice were bled from the retroorbital venous plexus with a heparinized pipette. Samples of blood (0.2 ml) were inoculated i.p. into naive susceptible mice. This route of administration can initiate either an immunizing or lethal infection depending on the number of rickettsiae in the challenge inoculum (11) . To show whether an immunizing, nonlethal dose was present in the inoculum, recipient animals which survived 28 days after the blood challenge were rechallenged with 1,000 MLD50 of the Karp strain by the i.p. route (see above). Those mice whose blood induced either death or protection in recipients as noted above were considered to be rickettsemic at the time they were bled. To establish that rickettsiae were responsible for death in recipient animals, a control study was performed in which previously immunized mice which demonstrated specific antibody titers (see below) also received the challenge inoculum. These specifically immune mice did not succumb to infection.
Quantification of rickettsemia. Infected mice were anesthetized with C02, partially exsanguinated with heparinized pipettes after incision of the right axillary artery, and then killed by cervical dislocation. Mouse blood was pooled, and 10-fold serial dilutions were injected i.p. into naive mice, five mice per dilution, which were monitored for 28 days. Surviving mice were rechallenged with 1,000 MLD50 of Karp strain i.p. and monitored again for 28 days (see above). The 50% mouse infective dose was determined by using the Spearman-Karber method of analysis for quantal responses (7) . The control consisted of 50% mouse infective dose determination for unirradiated, infected mice.
Modification of recrudescence with radioprotective drugs.
The drug S-2(3-aminopropylamino)ethyl phosphorothioic acid was used to determine whether radiation-induced rickettsemia could be modified. Due to the extensive experimentation conducted at Walter Reed Army Institute of Research with this phosphorothioate, it has been identified commonly in the literature as WR 2721. For reader conve- nience, that nomenclature is also used in this study.
All inoculations of WR 2721 were administered to BALB/cDub and C3H/HeDub mice in a volume of 0.2 ml by the i.p. route. The drug dose was varied, when appropriate, by diluting WR 2721 in distilled water. The drug was prepared fresh each time, 15 to 30 min before inoculation. Normal and infected mice were exposed to various doses of gamma radiation within 30 min after receiving the WR 2721. The survival and percentage of mice demonstrating rickettsemia were monitored as described above.
Influence of the humoral response. Circulating antibody in infected mice was quantified periodically after irradiation. Titers were compared to those observed in similar infected, but unirradiated, animals. Infected mice were bled from the retroorbital venous plexus at various times after irradiation, and sera were pooled and frozen. Rickettsial antibody titers were determined by a microimmunofluorescence test (19) . Known positive and negative mouse sera were tested simultaneously as controls.
RESULTS
Mouse scrub typhus model rationale. The mouse scrub typhus models used in this investigation included BALB/cDub mice inoculated s.c. with the Karp strain of R.
tsutsugamushi, BALB/cDub mice inoculated s.c. with the Gilliam strain, and C3H/HeDub mice inoculated s.c. with Gilliam strain. These models permitted the comparison of different virulence determinants in this examination of rickettsial recrudescence. The determinants consisted of (i) genetically determined variation in susceptibility of mouse strains to scrub typhus, i.e., BALB/cDub versus C3H/HeDub, and (ii) strain variation of the rickettsiae, i.e., Karp versus Gilliam. Since the i.p. inoculation of either mouse strain with Karp was uniformly lethal, the i.p. versus s.c. routes of inoculation were not compared in chronically infected mice.
Although these determinants have long been individually recognized (3, 9-11, 16), there has not yet been a comparative examination of interrelationships of the individual parameters. Whereas the i.p. inoculation of either mouse strain with 1,000 MLD50 of the Karp strain of R. tsutsugamushi was uniformly lethal for those mice, the s.c. inoculation with the same quantity of rickettsiae rendered both mouse strains immune to subsequent i.p. challenge. However, although the i.p. inoculation of the Gilliam strain of R. tsutsugamushi was lethal for C3H/HeDub mice, the similar i.p. inoculation of Gilliam rickettsiae into BALB/cDub mice was not lethal but immunized against the normally lethal Karp i.p. challenge.
Effect of radiation on normal and infected mice. The MLD50 of gamma radiation for normal BALB/cDub mice was 604 rads, this was significantly lower than for normal C3H/HeDub mice, which was 653 rads (Table 1) (P < 0.05). Mice which had been infected with R. tsutsugamushi Karp or Gilliam 12 weeks before radiation exposure died from lower radiation doses than did normal animals. The radiation MLD50 of BALB/cDub mice infected with strain Karp was 532 rads, and similar animals infected with strain Gilliam had a radiation MLD50 of 541 rads. The difference in the effect of radiation on normal and infected animals was even more pronounced in C3H/HeDub mice inoculated with Gilliam. In this case, the radiation MLD50 was substantially diniinished and infected animals succumbed after receiving only 505 rads. In further studies the radiation levels used for qualitative and quantitative determinations of rickettsemia were 450 and 500 rads. Those levels proved low enough to have sufficient survivors for the rickettsemia investigations but proved sufficient to induce a sublethal rickettsemia.
Qualitative evaluation of recrudescence. To determine whether sublethal radiation of mice resulted in measured proliferation of rickettsiae in any or all of the mouse scrub typhus systems investigated, whole blood from these animals was examined for the presence of virulent organisms. There was a dramatic increase in the number of BALB/cDub mice undergoing a Karp rickettsemia after exposure to 450 or 500 rads (Fig. 1 ). This effect was most pronounced 14 exhibiting a rickettsemia had returned to normal values. The effect of irradiation on rickettsemia in Gilliam-infected C3H/HeDub mice was similar to that observed in Karpinfected BALB/cDub animals ( Fig. 2) . At 14 days after radiation, at least 90% of the mice exhibited virulent Gilliam organisms in the blood. By day 35, the effect of radiation was no longer evident, and only a small percentage of animals showed rickettsemia. In contrast to the BALB/cDub-Karp model system, the C3H/HeDub mice infected with Gilliam demonstrated rickettsemia in a greater percentage of the animals before irradiation. The results obtained with the BALB/cDub-Gilliam model (Fig. 3) indicate that gamma radiation in the range of 450 to 500 rads has little effect on Gilliam rickettsiae. The percentage of unirradiated animals with circulating Gilliam rickettsiae was lower than in the two other models, and exposure to radiation did not cause a substantial increase in the percentage of animals showing rickettsemia through day 35.
We concluded it possible that radiation-induced recru- descence is dependent upon the interval between initial infection and exposure to sublethal gamma radiation. To investigate radiation effects on long-term chronic infection, Karp-infected BALB/cDub mice were exposed to 450 rads 1 year after initial infection. Radiation exposure caused all of these animals to exhibit rickettsemia within 14 days (Fig. 4) . Unlike the animals irradiated 12 weeks after infection, surviving mice remained rickettsemic through the 35-day observation period.
Quantification of rickettsemia. The qualitative evaluation of rickettsemia indicated clearly that gamma radiation induced rickettsemia in chronically infected animals. To more fully investigate the degree of rickettsemia, we quantified the virulent organisms circulating in the blood after various doses of radiation. This investigation included the BALB/cDub-Karp and C3H/HeDub-Gilliam model systems, since measurable differences in these two models were noted in the qualitative evaluation of rickettsemia. The I-I . BALB/cDub-Gilliam model was excluded, however, since the qualitative data (Fig. 3) indicated minimal rickettsemia. Figure 5 shows the level of Karp rickettsemia in BALB/cDub mice after exposure to 450, 500, or 550 rads of gamma radiation. The number of organisms in the blood was related to the radiation dose, and at approximately the radiation MLD50 for infected BALB/cDub mice (532 rads) rickettsiae were detected at a concentration of 103 organisms per ml. In these experiments, control infected animals had very low levels of circulating rickettsiae (0 to 2 infected whole blood recipients per time point; MID50 < 0 by the Spearman-Karber method), and the radiation effect was interpreted easily. However, our experience from qualitative rickettsemia studies suggested that about 25% of nonirradiated, infected BALB/cDub mice normally sustained detect- able levels of virulent Karp organisms in the blood (day 0 in Fig. 1) .
Infection of C3H/HeDub mice with Gilliam produced a pattern of rickettsemia very similar to that observed with Karp-infected BALB/cDub mice (data not shown). However, the response observed with 500 rads was nearly identical to that seen at 550 rads. Both radiation doses produced a Gilliam rickettsemia which exceeded 102.5 virulent organisms per ml of whole blood. The radiation MLD50 of infected C3H/HeDub mice was 505 rads, and doses in excess of this had little further effect on induction of rickettsemia.
Humoral antibody. Quantification of circulating antibody in infected mice was accomplished periodically after irradiation. Titers were compared with those observed in similar infected, but unirradiated, animals. Circulating antibody was produced by infected animals before irradiation, since titers remained stable in both irradiated and unirradiated animals, but subsequent in vivo events which permitted high levels of virulent rickettsiae to circulate in the blood in the presence of specific antibody were uncertain. Table 2 summarizes the indirect fluorescent antibody titers observed in Karpinfected BALB/cDub mice and Gilliam-infected C3H/HeDub mice. There was little variation in the titers observed in the BALB/cDub-Karp model system. Unirradiated, infected animals showed a consistent titer of approximately 320 throughout the observation period, and the titer was not affected by exposure of animals to 450 or 500 rads of gamma radiation. A similar phenomenon was observed in C3H/HeDub mice infected with Gilliam. It is clear that in both model systems there was substantial antibody present in the blood on days 14 and 21, which represented the period of maximum rickettsemia in irradiated animals.
Effect of radioprotective drug. The antiradiation compound WR 2721 increased the radiation MLD50 in C3H/HeDub mice. Protection was dose dependent; and at the largest dose employed, 500 mg/kg, all animals tested successfully resisted 800 rads of gamma radiation ( Table 3 ). The upper limit of radiation protection was not determined, but even these results present a dramatic difference from those observed in untreated C3H/HeDub animals, where uniform lethality was observed after exposure of mice to 750 or 800 rads (Table 1) .
A similar dose-dependent, radioprotective effect was found in BALB/cDub mice. All uninfected BALB/cDub animals receiving 500 mg/kg survived the 800-rad dose of gamma radiation, whereas all untreated mice succumbed to that radiation dose. 
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The sparing effect seen in uninfected animals was paralleled in Gilliam-infected C3H/HeDub mice. As might be expected, the magnitude of the sparing effect at each intermediate drug dose was less for chronically infected animals than for uninfected mice. At the maximum dose of WR 2721, Gilliam-infected C3H/HeDub mice were sufficiently protected from gamma radiation so that no deaths were observed after exposure of chronically infected mice to 800 rads, whereas the Karp-infected BALB/cDub animals receiving the same drug dose were less protected.
Occurrence of rickettsemia after prophylaxis with WR 2721. WR 2721 protected most infected mice from a radiation-induced lethal recrudescence of rickettsiae. It was anticipated that this protection might be mirrored by a qualitative reduction in the number of mice experiencing rickettsemia after radiation exposure. Figure 6 suggests that suppression of rickettsemia is a correlate of drug protection. The entire population of untreated Gilliam-infected C3H/HeDub mice quickly evidenced rickettsemia after exposure to 800 rads of gamma radiation, and by day 14 all had died. Those receiving 500 mg of WR 2721 per kg showed a modest increase in rickettsemia and maintained a level of chronicity seen earlier in infected, but unirradiated and untreated, animals (Fig. 2) . A large percentage of animals receiving the intermediate dosage (250 mg/kg) became rickettsemic by day 14, but drug protection was apparently sufficient for animals to control recrudescence, and the number of mice evidencing virulent rickettsiae in their blood returned to the normal, chronic level by day 35.
Similar results were noted in Karp-infected BALB/cDub mice (Fig. 7) . All untreated animals died by day 14; therefore, rickettsemia could not be monitored beyond day 7, at which time the percent rickettsemia had risen substantially from the chronic level. The increase in rickettsemia after treatment with 500 mg of WR 2721 per kg was slightly higher than in the C3H/HeDub-Gilliam system. Also similar to that system, BALB/cDub mice receiving the 250-mg/kg intermediate dose peaked by day 14 but gradually diminished by day 35. 
DISCUSSION
The data presented here clearly indicate that mice chronically infected with viable R. tsutsugamushi were induced by radiation to demonstrate a recrudescence of infection as evidenced by rickettsemia. This radiation-induced rickettsemia was observed up to 1 year after the initial infection and was lethal to animals irradiated at normally sublethal levels. The rickettsial recrudescence was evidenced by a substantially greater percentage of rickettsemic mice during the period after irradiation as well as by a quantal increase of rickettsiae.
Previous experiments from this laboratory have focused upon the effect of virulence determinants on acute and chronic scrub typhus infection though the examination of magnitude and duration of rickettsemia (14) . It was not clear whether those parameters were responsive to some mechanism of immune interdiction such as gamma irradiation. There is little published work which examines the effects of irradiation of animals which are chronically infected with rickettsiae. Zinsser, who distinguished epidemic typhus from the recrudescent form of that disease (26) , X irradiated rabbits and rats so as to affect the resistance of the animals while permitting them to live long enough for adequate multiplication of subsequently inoculated rickettsiae (27) . Susceptibility of X-irradiated mice and guinea pigs to the attenuated E strain of R. prowazekii has been examined (I. B. Fabrikant, Ph.D. thesis, University of Maryland, 1966) . In that study it was reported that sublethal doses of whole body X irradiation only slightly enhanced guinea pig susceptibility to infection with the strain.
The increased susceptibility of infected animals to gamma radiation could have resulted from an impairment of host physiological processes due to the rickettsial infection. However, mice sustain chronic experimental scrub typhus infections for periods in excess of 12 The in vivo target in animals subjected to sublethal irradiation appears to be the immune system (2). The lymphocyte is one of the most radiosensitive of mammalian cells (2, 15) . Radiation-induced depletion of lymphocytes in vivo is dose dependent up to the point of lethal irradiation; B cells are more radiosensitive than T cells (2) . Indeed, our studies show a radiation dose-dependent quantal response of circulating rickettsiae (Fig. 5) , although a precise correlation has not been proven.
In the course of this study specific circulating antibody to R. tsutsugamushi was present in elevated titers (.160); however, the presence of antibody failed to protect the animals, since mice demonstrating antibody were rickettsemic after irradiation and frequently died with normally sublethal levels of radiation. The prolonged presence of elevated antibody levels in mice chronically infected with R. tsutsugamushi is consistent with the results of others (M. G. Groves, unpublished data), but the precise role of antibody in limiting rickettsial replication during infection is unknown. Shirai et al. (20) indicated that the passive transfer of sera afforded protection against acute homologous scrub infection and hypothesized that antibody may be necessary to preclude recrudescence of the disease after infection. However, acquired resistance to infection can be transferred with T cell-enriched lymphocyte populations alone before the development of detectable antibody (20) . Jerrells and Eisemann have shown that T-cell function is necessary even in the presence of specific antibody (12) . Only when T-cell function for resistance was restored did "nude" BALB/c mice that were protected with specific antisera survive an i.p. challenge of 1,000 MLD50 of Karp rickettsiae (13) .
WR 2721 was used to determine whether radiationinduced rickettsemia could be modified. The proposed mechanism of action of this phosphorothioate compound appears related to an ability to scavenge radiation-induced free radicals (1) . Generally, the cause of damage within the immune system is molecular oxygen induced to the free radical state, which potentiates many of the radiation effects. This compound has been demonstrated by Davidson et al. to protect mice, dogs, and rhesus monkeys against gamma and X irradiation (6). Yuhas (24, 25) has demonstrated that the drug protects a variety of normal tissues, whereas solid animal tumors are not protected. Employing a dose of 600 mg/kg, Davidson et al. (6) demonstrated the drug would protect ICR mice against 825 rads (X ray) for 3 h after inoculation. In our studies this drug successfully protected both BALB/cDub and C3H/HeDub mice from normally lethal levels of radiation, although the chronically infected BALB/cDub mice were less protected. It seems possible that rickettsial recrudescence in these infected animals adds to their physiological stress and causes greater numbers of deaths than in the uninfected animals receiving the same doses of radiation and drug. In addition to the reduced lethality, drug-treated, infected animals were qualitatively less rickettsemic than were untreated, chronically infected mice. WR 2721 clearly modified radiation-induced lethality and rickettsial recrudescence in the model system studied.
The results of this study emphasize the role of differential host susceptibility in radiation-induced rickettsial recrudescence. BALB/cDub and C3H/HeDub mice chronically infected with Karp and Gilliam strains of R. tsutsugamushi, which are virulent for the respective inbred mouse strains when inoculated by the i.p. route, recrudesce after irradiation. In contrast, BALB/c mice chronically infected with the Gilliam strain, which is avirulent for that inbred mouse strain, fail to recrudesce after irradiation. The precise mechanism defining differential susceptibility to recrudescence remains undetermined. Clearly further evaluation of rickettsial recrudescence must be defined within the parameters of genetic background of the host.
